| 序号 |
标题 |
次数 |
作者 |
发布时间 |
| 1126 |
萨力多胺-NH-C10-酸，cas:2428400-33-1，Thalidomide-NH-C10-COOH |
7 |
zcy |
2024-11-21 |
| 1127 |
p-SCN-Bn-DOTA ； cas：127985-74-4 |
9 |
wyh |
2024-11-21 |
| 1128 |
127985-74-4 ；p-SCN-Bn-DOTA |
8 |
wyh |
2024-11-21 |
| 1129 |
cas:2341796-74-3，(S,R,S)-AHPC-C10-NH2 (VH032-C10-NH2)，烷基链化合物或碳链化合物 |
8 |
zcy |
2024-11-21 |
| 1130 |
G-C8-AF，CAS:73051-69-1，2′-脱氧-8-(9H-芴-2-基氨基)-鸟苷 |
10 |
zcy |
2024-11-21 |
| 1131 |
DOTA-Conjugated肽 |
4 |
zyl |
2024-11-21 |
| 1132 |
cas:204318-14-9 DOTA-(Tyr3)-Octreotate |
6 |
zyl |
2024-11-21 |
| 1133 |
DOTA-cyclo(RGDyK),DOTA标记多肽 |
7 |
zyl |
2024-11-21 |
| 1134 |
cas:753421-63-5 DOTA-C4-NH2 |
8 |
zyl |
2024-11-21 |
| 1135 |
cas:1262403-92-8 十三肽DOTA-LGEYGFQNALIVR |
7 |
zyl |
2024-11-21 |
| 1136 |
DOTA-HYPYAHPTHPSW 大环化合物修饰多肽 |
7 |
zyl |
2024-11-21 |
| 1137 |
N-辛酰基-D-神经鞘氨醇，CAS:74713-59-0，C8-Ceramide |
10 |
zcy |
2024-11-21 |
| 1138 |
DOTA-Ala-Ala-Tyr-COOH，具有特定氨基酸序列的多肽 |
7 |
zyl |
2024-11-21 |
| 1139 |
DOTA Acrylamide，DOTA 丙烯酰胺 |
7 |
zyl |
2024-11-21 |
| 1140 |
DOTA-NHS ester , 170908-81-3 |
9 |
wyh |
2024-11-21 |
| 1141 |
螯合剂多肽DOTA-c(RGDfK) |
8 |
zyl |
2024-11-21 |
| 1142 |
新型双功能螯合剂 ；Azido-mono-amide-DOTA-tris(t-Bu ester) |
9 |
wyh |
2024-11-21 |
| 1143 |
DOTA标记序列多肽,DOTA-E[c(RGDyK)2] |
8 |
zyl |
2024-11-21 |
| 1144 |
DOTA-Ala-Ala-Tyr-COOH；DOTA-丙氨酸-丙氨酸-酪氨酸-羧酸 |
5 |
wyh |
2024-11-21 |
| 1145 |
螯合剂多肽:DOTA-cyclo(RGDfK) |
7 |
zyl |
2024-11-21 |
| 1146 |
DOTA-E「c(RGDfK)2」的结构特点 |
9 |
wyh |
2024-11-21 |
| 1147 |
依多曲肽:204318-14-9,DOTA-(Tyr3)-octreotate |
5 |
zyl |
2024-11-21 |
| 1148 |
N3-DOTA-tBu ；DOTA螯合剂修饰多肽 |
7 |
wyh |
2024-11-21 |
| 1149 |
依多曲肽DOTA-(Tyr3)-octreotate,204318-14-9 |
5 |
zyl |
2024-11-21 |
| 1150 |
250612-06-7 DOTA-E[CYCLO(RGDFK)]2 |
7 |
wyh |
2024-11-21 |
| 1151 |
cas:479081-06-6 DOTA-(COOt-Bu)3-NHFmoc-Lys |
9 |
zyl |
2024-11-21 |
| 1152 |
DOTA标记多肽 ；DOTA-cyclo(RGDyK) |
8 |
wyh |
2024-11-21 |
| 1153 |
DOTA-RGD,大环螯合物DOTA |
7 |
zyl |
2024-11-21 |
| 1154 |
DOTA-cyclo(RGDfK) 螯合剂多肽 |
7 |
wyh |
2024-11-21 |
| 1155 |
DOTA-cyclo(RGDyK) DOTA标记多肽 |
6 |
zyl |
2024-11-21 |
| 1156 |
C8-鞘氨醇，cas:133094-50-5，C8-Sphingosine |
10 |
zcy |
2024-11-21 |
| 1157 |
cyclo(RGDFK(DOTA))，DOTA-c(RGDfK) |
11 |
wyh |
2024-11-21 |
| 1158 |
Gd-DOTA-多肽 |
15 |
zyl |
2024-11-21 |
| 1159 |
大环配体多肽DOTA-奥曲肽 |
6 |
wyh |
2024-11-21 |
| 1160 |
C8-C13异构醇，cas:68989-27-5，Alcohols, C8-13-iso- |
6 |
zcy |
2024-11-21 |
| 1161 |
螯合剂DOTA修饰聚合物 |
6 |
zyl |
2024-11-21 |
| 1162 |
微球接枝DOTA螯合剂 |
5 |
zyl |
2024-11-21 |
| 1163 |
DOTA-3-酪氨酰基-奥曲肽 ；177943-89-4 |
4 |
wyh |
2024-11-21 |
| 1164 |
偶联功能基团的双功能螯合剂NOTA |
11 |
zyl |
2024-11-21 |
| 1165 |
DOTA-CH2-Alkynyl ；TFA salt |
6 |
wyh |
2024-11-21 |
| 1166 |
双功能螯合剂NOTA偶联糖类化合物 |
9 |
zyl |
2024-11-21 |
| 1167 |
DOTA-TATE, 177943-88-3，DOTA-奥曲肽 |
6 |
wyh |
2024-11-21 |
| 1168 |
依多曲肽 ；204318-14-9 ；DOTA-(Tyr3)-Octreotide |
5 |
wyh |
2024-11-21 |
| 1169 |
C13-DBCO的化学结构 |
6 |
wyh |
2024-11-21 |
| 1170 |
C8神经酰胺-1-磷酸；CAS:887353-95-9；C8 Ceramide-1-phosphate |
7 |
zcy |
2024-11-21 |
齐岳微信公众号
官方微信
库存查询